86 Potent anti-tumor activity of T-DM1 antibody–drug conjugate in combination with chemotherapeutic agents in breast tumor cells

K. Parsons; C. Fields; B. Gunter; G. Phillips; J. Tibbitts

首页> 外文期刊>European Journal of Cancer Supplements >86 Potent anti-tumor activity of T-DM1 antibody–drug conjugate in combination with chemotherapeutic agents in breast tumor cells

【24h】

86 Potent anti-tumor activity of T-DM1 antibody–drug conjugate in combination with chemotherapeutic agents in breast tumor cells

机译：86 T-DM1抗体-药物结合物与化学治疗剂联合对乳腺癌细胞的有效抗肿瘤活性

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2010年第7期|共页
作者
K. Parsons; C. Fields; B. Gunter; G. Phillips; J. Tibbitts;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Selectively Targeting Checkpoint Kinase By Prexasertib Had Potent Anti-Tumor Activity As Single Agent or Combined with Other Chemotherapeutic Drugs in Diffuse Large B Cell Lymphoma, Especially Double Hit Lymphoma [J] . Gu Juan, Gaughan Dennis C., Gill Simran, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：Prexasertib选择性靶向检查点激酶具有效力的抗肿瘤活性作为单一剂或与其他化学治疗药物联合弥漫性大B细胞淋巴瘤，尤其是双击淋巴瘤
2. A novel antibody-drug conjugate, HcHAbl8-DMl, has potent anti-tumor activity against human non-small cell lung cancer [J] . Muren Huhe, Jiaxin Lou, Yumeng Zhu, Biochemical and Biophysical Research Communications . 2019,第4期

机译：一种新型抗体 - 药物缀合物HCHabl8-DML，对人类非小细胞肺癌具有有效的抗肿瘤活性
3. 620?Tumor cell-intrinsic STING pathway is activated in the presence of cues from immune cells and contributes to the anti-tumor activity of tumor cell-targeted STING agonist antibody-drug conjugates [J] . Naniye Malli Cetinbas, Travis Monnell, Winnie Lee, Journal for ImmunoTherapy of Cancer . 2020,第Suppla3期

机译：620？肿瘤细胞内在术术在免疫细胞的提示存在下活化，有助于肿瘤细胞靶向刺激剂抗体 - 药物缀合物的抗肿瘤活性
4. KTN0182A, an Anti-KIT, Pyrrolobenzodiazepine (PBD)-Containing Antibody Drug Conjugate (ADC) Demonstrates Potent Antitumor Activity In Vitro and In Vivo Against a Broad Range of Tumor Types [C] . Sergio Trombetta, Christine Lubeski, Gary C. Kemp, PEGS . 2015

机译：KTN0182A，抗试剂盒，吡咯唑二氮杂己酮（PBD）抗体药物缀合物（ADC）在体外和体内抗抗肿瘤类型的抗肿瘤活性
5. Immunological consequences of antibody-tumor antigen interactions on the development of potent anti-tumor immunity. [D] . Kim, Peter Sungwhan. 2007

机译：抗体-肿瘤抗原相互作用对有效抗肿瘤免疫力发展的免疫学后果。
6. RN765C a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models [O] . Oi Kwan Wong, Thomas-Toan Tran, Wei-Hsien Ho, 2018

机译：RN765C一种在临床前实体瘤模型中具有有效抗肿瘤活性的低亲和力EGFR抗体药物偶联物
7. RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models [O] . Oi Kwan Wong, Thomas-Toan Tran, Wei-Hsien Ho, 2018

机译：RN765C，一种低亲和力EGFR抗体药物缀合物，其临床正常肿瘤模型中具有有效的抗肿瘤活性

86 Potent anti-tumor activity of T-DM1 antibody–drug conjugate in combination with chemotherapeutic agents in breast tumor cells

著录项

相似文献

相关主题

期刊订阅